Financhill
Buy
54

PPERY Quote, Financials, Valuation and Earnings

Last price:
$12.92
Seasonality move :
6.23%
Day range:
$12.00 - $12.98
52-week range:
$10.25 - $20.07
Dividend yield:
8.53%
P/E ratio:
--
P/S ratio:
3.54x
P/B ratio:
2.05x
Volume:
36K
Avg. volume:
74.7K
1-year change:
-10.31%
Market cap:
$30.1B
Revenue:
--
EPS (TTM):
--

Analysts' Opinion

  • Consensus Rating
    No consensus rating exists at this time due to lack of analyst coverage.
  • Price Target Downside
    No price target exists because of limited analyst coverage.
  • Price Target Upside
    Similarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.

Fair Value

  • According to the consensus of 0 analysts, PT Bank Mandiri (Persero) Tbk has -- downside to fair value with a price target of -- per share.

PPERY vs. S&P 500

  • Over the past 5 trading days, PT Bank Mandiri (Persero) Tbk has underperformed the S&P 500 by -4.18% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • PT Bank Mandiri (Persero) Tbk does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • PT Bank Mandiri (Persero) Tbk has grown year-over-year revenues for 9 quarters straight. In the most recent quarter PT Bank Mandiri (Persero) Tbk reported revenues of --.

Earnings Growth

  • PT Bank Mandiri (Persero) Tbk has grown year-over-year earnings for 7 quarters straight. In the most recent quarter PT Bank Mandiri (Persero) Tbk reported earnings per share of --.
Enterprise value:
20.7B
EV / Invested capital:
--
Price / LTM sales:
3.54x
EV / EBIT:
4.00x
EV / Revenue:
2.42x
PEG ratio (5yr expected):
0.26x
EV / Free cash flow:
3.28x
Price / Operating cash flow:
4.78x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
Trailing 12 Months Fiscal Quarters
Period Ending 2020-12-31 2021-12-31 2022-12-31 2021-12-31 2022-12-31
Income Statement
Revenue $6.8B $7.8B $8.5B $2.2B $2.3B
Gross Profit -- -- -- -- --
Operating Income -- -- -- -- --
EBITDA -- -- -- -- --
Diluted EPS $0.50 $0.84 $1.19 $0.26 $0.29
Period Ending 2018-12-31 2019-12-31 2020-12-31 2021-12-31 2022-12-31
Balance Sheet
Current Assets $11.6B $12.4B $20.5B $19B $22.2B
Total Assets $83B $94.9B $107.9B $120.8B $127.5B
Current Liabilities $251M $266.8M $427.2M $388.1M $773.4M
Total Liabilities $70.2B $79.9B $93.6B $105.2B $111.4B
Total Equity $12.8B $15.1B $14.3B $15.5B $16.1B
Total Debt $4.7B $6.1B $6.3B $6.6B $6.9B
Trailing 12 Months Fiscal Quarters
Period Ending 2020-12-31 2021-12-31 2022-12-31 2021-12-31 2022-12-31
Cash Flow Statement
Cash Flow Operations $7.6B $9B $6.8B $3.4B $6.3B
Cash From Investing -$2.9B -$9.2B -$2.9B -$1.8B -$389.1M
Cash From Financing -$992.6M -$239.2M $897.8M $363.6M $119.7M
Free Cash Flow $7.1B $8.7B $6.3B $3.2B $6.1B
PPERY
Sector
Market Cap
$30.1B
$608.2M
Price % of 52-Week High
64.35%
87%
Dividend Yield
8.53%
2.03%
Shareholder Yield
--
4.07%
1-Year Price Total Return
-10.31%
10.08%
Beta (5-Year)
0.510
0.587
Dividend yield:
8.53%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
1 years

Technicals

8-day SMA
Sell
Level $13.08
200-day SMA
Sell
Level $14.78
Bollinger Bands (100)
Buy
Level 11.31 - 13.67
Chaikin Money Flow
Buy
Level 13.5M
20-day SMA
Buy
Level $12.50
Relative Strength Index (RSI14)
Buy
Level 59.48
ADX Line
Sell
Level 18.09
Williams %R
Neutral
Level -31.8333
50-day SMA
Buy
Level $11.96
MACD (12, 26)
Buy
Level 0.35
25-day Aroon Oscillator
Buy
Level 28
On Balance Volume
Neutral
Level 15.6M

Financial Scores

--
Altman Z-Score (Annual)
Level (--)
--
CA Score (Annual)
Level (--)
--
Beneish M-Score (Annual)
Level (--)
Sell
Momentum Score
Level (3)
--
Ohlson Score
Level (--)
--
Piotroski F Score (Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)

Revenue Forecast

Earnings per Share Forecast

Company Profile

PT Bank Mandiri (Persero) Tbk is a full-service bank principally operating in the Indonesian archipelago. The national government of Indonesia owns well over half of the bank's outstanding shares. Its various products and services includes deposit collection, loans, promissory note issuance, guarantee services, wholesale banking, custodian banking, asset and wealth management, factoring and credit card services, and Islamic banking. The bank emphasizes a cross-selling culture and increased regionalization, expertise-oriented solutions, and ease of access for its micro, small, and midsize enterprise customers. Its loan portfolio is diversified, mostly in industrials, restaurants and hospitality, and the transportation and storage industries.

Stock Forecast FAQ

In the current month, PPERY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The PPERY average analyst price target in the past 3 months is --.

  • Where Will PT Bank Mandiri (Persero) Tbk Stock Be In 1 Year?

    According to analysts, the consensus estimate is that PT Bank Mandiri (Persero) Tbk share price will drop to -- per share over the next 12 months.

  • What Do Analysts Say About PT Bank Mandiri (Persero) Tbk?

    Analysts are divided on their view about PT Bank Mandiri (Persero) Tbk share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that PT Bank Mandiri (Persero) Tbk is a Sell and believe this share price will rise from its current level to --.

  • What Is PT Bank Mandiri (Persero) Tbk's Price Target?

    The price target for PT Bank Mandiri (Persero) Tbk over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is PPERY A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for PT Bank Mandiri (Persero) Tbk is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of PPERY?

    You can purchase shares of PT Bank Mandiri (Persero) Tbk via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase PT Bank Mandiri (Persero) Tbk shares.

  • What Is The PT Bank Mandiri (Persero) Tbk Share Price Today?

    PT Bank Mandiri (Persero) Tbk was last trading at $12.92 per share. This represents the most recent stock quote for PT Bank Mandiri (Persero) Tbk. Yesterday, PT Bank Mandiri (Persero) Tbk closed at $12.92 per share.

  • How To Buy PT Bank Mandiri (Persero) Tbk Stock Online?

    In order to purchase PT Bank Mandiri (Persero) Tbk stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will Salesforce Stock Be in 5 Years?
Where Will Salesforce Stock Be in 5 Years?

Salesforce (NYSE: CRM) just turned in a quarter that, on…

2 Ultra Safe Dividend Stocks to Buy Now
2 Ultra Safe Dividend Stocks to Buy Now

Historically, blue-chip dividend stocks have been good choices for periods…

Where Will Asana Stock Be in 5 Years?
Where Will Asana Stock Be in 5 Years?

Asana stock hasn’t given many investors on Wall Street any…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy
65
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Sell
31
REGN alert for May 31

Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.

Buy
55
RGC alert for May 31

Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.

Sell
42
AMBA alert for May 31

Ambarella [AMBA] is down 15.13% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock